145 related articles for article (PubMed ID: 31863330)
1. miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters.
Boubaker NS; Spagnuolo M; Trabelsi N; Said R; Gurtner A; Regazzo G; Ayed H; Blel A; Karray O; Saadi A; Rammeh S; Chebil M; Rizzo MG; Piaggio G; Ouerhani S
Mol Biol Rep; 2020 Feb; 47(2):1283-1292. PubMed ID: 31863330
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.
Setti Boubaker N; Gurtner A; Trabelsi N; Manni I; Ayed H; Saadi A; Naimi Z; Ksontini M; Ayadi M; Blel A; Rammeh S; Chebil M; Piaggio G; Ouerhani S
Mol Biol Rep; 2020 Nov; 47(11):8819-8830. PubMed ID: 33128684
[TBL] [Abstract][Full Text] [Related]
3. The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.
Setti Boubaker N; Cicchillitti L; Said R; Gurtner A; Ayed H; Blel A; Karray O; Essid MA; Gharbi M; Bouzouita A; Rammeh Rommeni S; Chebil M; Piaggio G; Ouerhani S
Mol Biol Rep; 2019 Oct; 46(5):4743-4750. PubMed ID: 31214962
[TBL] [Abstract][Full Text] [Related]
4. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
Spagnuolo M; Costantini M; Ferriero M; Varmi M; Sperduti I; Regazzo G; Cicchillitti L; Díaz Méndez AB; Cigliana G; Pompeo V; Russo A; Laquintana V; Mastroianni R; Piaggio G; Anceschi U; Brassetti A; Bove A; Tuderti G; Flammia RS; Gallucci M; Simone G; Rizzo MG
J Exp Clin Cancer Res; 2020 Apr; 39(1):68. PubMed ID: 32303246
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M
J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887
[TBL] [Abstract][Full Text] [Related]
6. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
[TBL] [Abstract][Full Text] [Related]
8. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
[TBL] [Abstract][Full Text] [Related]
10. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
[TBL] [Abstract][Full Text] [Related]
11. Evaluating prognostic utility of preoperative Neutrophil to Lymphocyte Ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer.
Boubaker NS; Gurtner A; Trabelsi N; Manni I; Said R; Ayed H; Ksentini M; Karray O; Saadi A; Essid MA; Blel A; Rammeh S; Chebil M; Piaggio G; Ouerhani S
Cancer Biomark; 2020; 27(1):63-73. PubMed ID: 31683460
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
13. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
[TBL] [Abstract][Full Text] [Related]
14. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of seven CpG island-harboring miRNAs in bladder cancer: miR-155 and miR-23b as the most promising oncomiRs.
Pençe S; Özbek E; Ozan Tiryakioğlu N; Ersoy Tunali N
Cell Mol Biol (Noisy-le-grand); 2016 Mar; 62(3):25-30. PubMed ID: 27064870
[TBL] [Abstract][Full Text] [Related]
16. microRNA expression profiles as decision-making biomarkers in the management of bladder cancer.
Amir S; Mabjeesh NJ
Histol Histopathol; 2017 Feb; 32(2):107-119. PubMed ID: 27586262
[TBL] [Abstract][Full Text] [Related]
17. Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
Zhao YG; Shi BY; Qian YY; Bai HW; Xiao L; He XY
Tumori; 2014; 100(6):e273-81. PubMed ID: 25688510
[TBL] [Abstract][Full Text] [Related]
18. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
